Dr. Marshall is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
601 Elmwood Ave
Rochester, NY 14642Phone+1 585-275-5006Fax+1 585-273-1255
Education & Training
Brigham and Women's Hospital/Massachusetts General Hospital/Harvard Medical SchoolResidency, Neurology, 1991 - 1994
UMass Chan - BaystateInternship, Internal Medicine, 1989 - 1990
Harvard Medical SchoolClass of 1989
Certifications & Licensure
NY State Medical License 1994 - 2027- American Board of Psychiatry and Neurology Neurology
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2012
- Whos Who in Medicine and Healthcare Marquis Whos Who
Clinical Trials
- Neurobiological Predictors of Huntington's Disease (PREDICT-HD) Start of enrollment: 2002 Aug 01
- Effects of Music Therapy on Huntington's Disease Start of enrollment: 2004 Jul 01
- Cellcept for Treatment of Juvenile Neuronal Ceroid Lipofuscinosis Start of enrollment: 2011 Jul 01
- Join now to see all
Publications & Presentations
PubMed
- 15 citationsSafety and Tolerability of SRX246, a Vasopressin 1a Antagonist, in Irritable Huntington's Disease Patients-A Randomized Phase 2 Clinical Trial.Michael J Brownstein, Neal G. Simon, Jeffrey D. Long, Jon W. Yankey, Hilda T Maibach
Journal of Clinical Medicine. 2020-11-16 - 11 citationsThe CLN3 Disease Staging System: A New Tool for Clinical Research in Batten DiseaseMargaux C. Masten, Justin D. Williams, Jennifer Vermilion, Heather R. Adams, Amy Vierhile
Neurology. 2020-06-09 - 1 citationsA novel, hybrid, single- and multi-site clinical trial design for CLN3 disease, an ultra-rare lysosomal storage disorder:Heather R. Adams, Sara Defendorf, Amy Vierhile, Jonathan W. Mink, Frederick J. Marshall
Clinical Trials. 2019-06-11
Press Mentions
URMC to Lead First Gene Therapy Study for Batten DiseaseNovember 3rd, 2021
New Grants Will Accelerate Clinical Trials in Rare Neurological DisordersJune 26th, 2019
Professional Memberships
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
